Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S O'Keefe

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Journal of Long-Term Effects of Medical Implants|December 9, 1994
Evolution of powered surgical instrumentsE J Messer, R S Carlson, J S O'Keefe, et al.
Prostaglandins & Other Lipid Mediators|December 14, 2006
DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylationU P Kelavkar, N S Harya, J Hutzley, et al.
New Zealand Veterinary Journal|March 7, 2008
Infection trials in pigs with a human isolate of Brucella ( isolate 02/611 'marine mammal type' )J Bingham, T K Taylor, J E Swingler, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 15, 2004
Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitorD Claveau, S L Chen, S O'Keefe, et al.
Journal of Neurochemistry|September 30, 2005
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injuryDean J Bacich, Krystyna M Wozniak, X-C May Lu, et al.
Investigational New Drugs|November 15, 2006
Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumorsS Kalmadi, M Davis, A Dowlati, et al.
Journal of Virology|May 28, 2010
Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 proteinIleana M Cristea, Nathaniel J Moorman, Scott S Terhune, et al.
Genomics|May 15, 2001
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1F Watt, A Martorana, D E Brookes, et al.
The Prostate|February 11, 2011
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folateJeffrey J Tomaszewski, Jessica L Cummings, Anil V Parwani, et al.
Clinical Orthopaedics and Related Research|January 8, 2025
Does the Relationship Between Preoperative Function and Achievement of Clinically Important Benchmarks of Success After Total Shoulder Arthroplasty Depend on Outcome Assessment Design?Kevin A Hao, Keegan M Hones, Daniel S O'Keefe, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Journal of Long-Term Effects of Medical Implants|December 9, 1994
Evolution of powered surgical instrumentsE J Messer, R S Carlson, J S O'Keefe, et al.
Prostaglandins & Other Lipid Mediators|December 14, 2006
DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylationU P Kelavkar, N S Harya, J Hutzley, et al.
New Zealand Veterinary Journal|March 7, 2008
Infection trials in pigs with a human isolate of Brucella ( isolate 02/611 'marine mammal type' )J Bingham, T K Taylor, J E Swingler, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 15, 2004
Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitorD Claveau, S L Chen, S O'Keefe, et al.
Journal of Neurochemistry|September 30, 2005
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injuryDean J Bacich, Krystyna M Wozniak, X-C May Lu, et al.
Investigational New Drugs|November 15, 2006
Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumorsS Kalmadi, M Davis, A Dowlati, et al.
Journal of Virology|May 28, 2010
Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 proteinIleana M Cristea, Nathaniel J Moorman, Scott S Terhune, et al.
Genomics|May 15, 2001
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1F Watt, A Martorana, D E Brookes, et al.
The Prostate|February 11, 2011
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folateJeffrey J Tomaszewski, Jessica L Cummings, Anil V Parwani, et al.
Clinical Orthopaedics and Related Research|January 8, 2025
Does the Relationship Between Preoperative Function and Achievement of Clinically Important Benchmarks of Success After Total Shoulder Arthroplasty Depend on Outcome Assessment Design?Kevin A Hao, Keegan M Hones, Daniel S O'Keefe, et al.
Pageof 11